Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.

Liu Y, Nonnemacher MR, Stauff DL, Li L, Banerjee A, Irish B, Kilareski E, Rajagopalan N, Suchitra JB, Khan ZK, Ranga U, Wigdahl B.

Biomed Pharmacother. 2010 Dec;64(10):672-80. doi: 10.1016/j.biopha.2010.09.007. Epub 2010 Sep 25.

2.
4.

CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.

Dahiya S, Liu Y, Nonnemacher MR, Dampier W, Wigdahl B.

PLoS One. 2014 Feb 14;9(2):e88116. doi: 10.1371/journal.pone.0088116. eCollection 2014.

5.

Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.

Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B.

J Virol. 2000 Apr;74(8):3740-51.

7.

HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.

Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B.

J Neurovirol. 2001 Jun;7(3):235-49.

PMID:
11517398
8.
9.

Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat.

Nonnemacher MR, Hogan TH, Quiterio S, Wigdahl B, Henderson A, Krebs FC.

Biomed Pharmacother. 2003 Jan;57(1):34-40.

PMID:
12642035
10.

C/EBP- and Tat-mediated activation of the HIV-1 LTR in CD34+ hematopoietic progenitor cells.

Quiterio S, Grant C, Hogan TH, Krebs FC, Wigdahl B.

Biomed Pharmacother. 2003 Jan;57(1):49-56.

PMID:
12642037
13.

Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.

McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.

Virology. 2000 Sep 1;274(2):262-77.

14.

Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.

Shah S, Alexaki A, Pirrone V, Dahiya S, Nonnemacher MR, Wigdahl B.

Virol J. 2014 May 16;11:92. doi: 10.1186/1743-422X-11-92.

15.
16.

HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific.

Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B.

Biomed Pharmacother. 2003 Jan;57(1):41-8.

PMID:
12642036
18.

CCAAT/enhancer-binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation.

Grant C, Nonnemacher M, Jain P, Pandya D, Irish B, Williams SC, Wigdahl B.

Virology. 2006 May 10;348(2):354-69. Epub 2006 Feb 3.

19.
20.

Interplay between viral Tat protein and c-Jun transcription factor in controlling LTR promoter activity in different human immunodeficiency virus type I subtypes.

van der Sluis RM, Derking R, Breidel S, Speijer D, Berkhout B, Jeeninga RE.

J Gen Virol. 2014 Apr;95(Pt 4):968-79. doi: 10.1099/vir.0.059642-0. Epub 2014 Jan 21.

PMID:
24447950

Supplemental Content

Support Center